McKenna SP, Wilburn J, Crawford SR, Aryamanesh M, Twiss J. New developments in the Ankylosing Spondylitis Quality of Life (ASQOL) scale. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A314.
Stull DE, Houghton KF, Gale R, Wiklund I, Capkun-Niggli G, Jones P. Application of innovative methods to identify and characterize differential responders in clinical trials of COPD: the use of mixture models. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A501-2.
Stull DE, Houghton K. Examining variability in depression among pre-retirees: innovative analytic methods applied to observational data. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. [abstract] Value Health. 2011 Nov; 14(7):A301.
Palsgrove A, Houghton KF, Hareendran A, Schaefer M, Setyawan J, Mocarski M, Carson R, Make B. The development of the early morning symptoms of COPD instrument (EMSCI). Poster presented at the 2011 ISPOR 14th Annual European Congress; November 16, 2011. [abstract] Value Health. 2011 Nov; 14(7):A496-7.
Wilburn J, McKenna S, Crawford SR, Perry-Hinsley D, Bayat A. Determining the true impact of dupuytren's disease: a qualitative study. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A314-5.
Mitra D, Trask P, Iyer S, Candrilli S, Kaye J. A multi-country retrospective study of patient characteristics and treatment patterns in chronic myeloid leukemia. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 10, 2011. [abstract] Value Health. 2011 Nov; 14(7):A468.
Twiss J, McKenna SP, Bloch M, Bonney M. Patient and clinician perceived benefit of early consumption of famciclovir for the treatment of herpes outbreaks. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A266. doi: 10.1016/j.jval.2011.08.193
Candrilli SD, Bell CF, Davis KL. Recent trends in muscular dystrophy-related inpatient care among pediatric patients in the United States. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A320.
Earnshaw SR, McDade CL, Zanotti G, Farkouh R, Strutton D. Cost-effectiveness of 2+1 dosing of 13-valent pneumococcal conjugate vaccine compared with 2+1 dosing of 10-valent conjugate vaccine in preventing pneumococcal disease in Canada. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. [abstract] Value Health. 2011 Nov; 14(7):A275.
Clark M, Hofmann A, Tabberer M, Martin S. Development and content validity of the COPD device preference questionnaire. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. [abstract] Value Health. 2011 Nov; 14(7):A255.
Spinner DS, Mladsi D, Walter J, Ziemiecki R, Stafford-Smith M, Taekman J, Faulkner E. Clinical trial learning curves may impact both clinical and economic outcomes and influence health technology assessment and reimbursement decision making. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A356.
Ascher-Svanum H, Novick D, Haro J, Aguado J, Cui Z, Anand H. Empirically-driven definitions of 'good', 'moderate' and 'poor' levels of functioning in the treatment of schizophrenia. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A287. doi: 10.1016/j.jval.2011.08.307
Sood V, Braun L, Hogue S, Davis K, Copley-Merriman C, Lieberman B. Chronic kidney disease burdens patients, health care systems, and employers. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. [abstract] Value Health. 2011 Nov; 14(7):A331.
Sennfalt K, Ling CS, Pericleous L, Sbarigia U, Gatta F, Kolasa K, Chamberlain G, Pandit P, Zagorska G. The economic burden of post-transplant events in renal transplant patients in UK, Italy, Netherlands, Poland and Belgium. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research; 2011. [abstract] Value Health. 2011 Nov; 14(7):A262-3.
Crawford SR, McKenna SP, Twiss J, Tammaru M, Oprandi NC. Further developments of the Asthma Life Impact Scale (ALIS). Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. [abstract] Value Health. 2011 Nov; 14(7):A497. doi: 10.1016/j.jval.2011.08.1440
Crawford SR, McKenna SP, Twiss J, Tammaru M, Oprandi NC. Further developments of the Living with Chronic Obstructive Pulmonary Disease (LCOPD). Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. [abstract] Value Health. 2011 Nov; 14(7):A497.
Hicks KA, Karve S, Vlahiotis A, Frazee S, Tian Y, Earnshaw SR. Estimation of increases in direct medical expenditures associated with medication nonadherence and potential savings from increased adherence. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. [abstract] Value Health. 2011 Nov; 14(7):A343-4.
Dalal AA, Nelson L, Gilligan T, McLeod L, Lewis S, Demuro-Mercon C. Evaluating patient-reported outcome measurement comparability between paper and alternate versions, using the lung function questionnaire as an example. Value Health. 2011 Jul 1;14(5):712-20.
Brogan AJ, Talbird SE, Cohen C. Cost-effectiveness of nucleoside reverse transcriptase inhibitor pairs in efavirenz-based regimens for treatment-naïve adults with HIV infection in the United States. Value Health. 2011 Jul 1;14(5):657-554.
Dalal AA, Nelson L, Gilligan TM, McLeod LD, Lewis SE, DeMuro C. Measurement comparability between paper and alternate versions: recommended assessment steps using the lung function questionnaire as an example. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 25, 2011. [abstract] Value Health. 2011 May; 14(3):A145.
Palsgrove A, Schaefer M, Hareendran A, Houghton KF, Mocarski M, Carson R, Make B. The development of a patient-reported outcome instrument to evaluate nighttime symptoms of COPD. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 2011. Baltimore, MD. [abstract] Value Health. 2011 May; 14(3):A141-2. doi: 10.1016/j.jval.2011.02.788
Mitra D, Candrilli SD. Acute lymphocytic leukemia–related inpatient care among pediatric patients in the United States. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 25, 2011. [abstract] Value Health. 2011 May; 14(3):A163.
Gilligan TM, Nelson L, Dalal AA, McLeod LD. Visually evaluating the measurement comparability between paper-based and alternate versions of administration of the lung function questionnaire. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 25, 2011. [abstract] Value Health. 2011 May; 14(3):A153.
Candrilli SD, Karve SJ, Wirth PE. Complications arising during hospitalization for hemorrhagic or ischemic stroke: evidence from a large administrative database. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 25, 2011. [abstract] Value Health. 2011 May; 14(3):A51.
Mauskopf J, Chirila C, Masaquel CJ, Boye KS, Bowman L, Birt J, Grainger DB. The relationship between financial impact and the likelihood of drug reimbursement in the Australian health care system. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 26, 2011. [abstract] Value Health. 2011 May; 14(3):A22-3.
Yen L, Davis KL, Longstreth G, Streck P, Hodgkins P. Resource utilization and health care costs associated with diverticular disease: results from a retrospective claims database analysis in the United States. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 2011. Baltimore, MD. [abstract] Value Health. 2011 May; 14(3):A183.
Coon CD, McLeod LD, Arnold LM, Chandran A, Martin S. Evaluating the screening ability of patient-reported outcome instruments. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 25, 2011. [abstract] Value Health. 2011 May; 14(3):A151.
Mordin M, Clark M, DeMuro C, Evans ED, Copley-Merriman K, Fehnel S, Gnanasakthy A. Pro label claims: an analysis based on a review of pros among new molecular entities and biologic license applications 2006-2010. Poster presented at the 2011 ISPOR 16th Annual International Meeting; June 3, 2011. [abstract] Value Health. 2011 May; 14(3):A29.
DeMuro C, Mordin M, Evans ED, Copley-Merriman K, Fehnel S, Gnanasakthy A. Reasons for rejection of PRO label claims: an analysis based on a review of PRO use among new molecular entities and biologic license applications 2006–2010. Poster presented at the 2011 ISPOR 16th Annual International Meeting; June 3, 2011. [abstract] Value Health. 2011 May; 14(3):A29.
Coleman C, Chang S, Copley-Merriman K, Masaquel CJ, Hubble J. Health-related quality-of-life improvements with dysport in cervical dystonia. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 26, 2011. [abstract] Value Health. 2011 May; 14(3):A210.
Johnson ML, Parikh R, Rajan SS, Aparasu R. Effect of ACEI and ARB on health related quality of life in patients with hypertension and diabetes. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 2011. Baltimore, MD. [abstract] Value Health. 2011 May; 14(3):A46.
Mehta HB, Patel J, Parikh R, Abughosh S. Predictors of obesity treatment (counseling or pharmacotherapy) in ambulatory settings. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 2011. Baltimore, MD. [abstract] Value Health. 2011 May; 14(3):A68.
Meyers JL, Meyers S. Inpatient costs of low birth weight and pre-term infant stays in the United States in 2008. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 31, 2011. [abstract] Value Health. 2011 May; 14(3):A107.
Lançon C, DiBenedetti DB, Lewis SA, Davis KH, Danchenko N, François C. Assessing the impact of major depressive disorder (MDD) on family functioning: development of the depression and family functioning scale. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 2011. Baltimore, MD. [abstract] Value Health. 2011 May; 14(3):A195.
Rothman KJ, Mosquin PL. Confounding after risk-set sampling in the beryllium study of sanderson et al. Ann Epidemiol. 2011 Apr 15;21(10):773-9.